Literature DB >> 10923763

Massive increase in serum creatine kinase during olanzapine and quetiapine treatment, not during treatment with clozapine.

E Boot, L de Haan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10923763     DOI: 10.1007/s002130000464

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  7 in total

1.  Olanzapine and NMS.

Authors:  C Hickey; C Stewart; S Lippmann
Journal:  Psychiatr Serv       Date:  1999-06       Impact factor: 3.084

2.  Marked elevations of serum creatine kinase activity associated with antipsychotic drug treatment.

Authors:  H Y Meltzer; P A Cola; M Parsa
Journal:  Neuropsychopharmacology       Date:  1996-10       Impact factor: 7.853

3.  Creatine kinase elevations with clozapine.

Authors:  M S Keshavan; J Stecker; R K Kambhampati
Journal:  Br J Psychiatry       Date:  1994-01       Impact factor: 9.319

4.  Neuroleptic malignant syndrome.

Authors: 
Journal:  N Engl J Med       Date:  1985-11-14       Impact factor: 91.245

5.  [Neuroleptic malignant syndrome after treatment with olanzapine].

Authors:  C Emborg
Journal:  Ugeskr Laeger       Date:  1999-03-08

6.  Neuroleptic malignant syndrome associated with olanzapine.

Authors:  V Johnson; G Bruxner
Journal:  Aust N Z J Psychiatry       Date:  1998-12       Impact factor: 5.744

7.  Racial differences in serum creatine kinase levels.

Authors:  H R Black; H Quallich; C B Gareleck
Journal:  Am J Med       Date:  1986-09       Impact factor: 4.965

  7 in total
  6 in total

1.  Massive serum creatine kinase increases with atypical antipsychotic drugs: what is the mechanism and the message?

Authors:  H Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  2000-06       Impact factor: 4.530

2.  Severe creatine kinase increase during quetiapine and mirtazapine treatment.

Authors:  Sule Apikoglu Rabus; Fikret Izzettin; Murat Rabus; Mustafa Bilici
Journal:  Psychopharmacology (Berl)       Date:  2005-12-23       Impact factor: 4.530

3.  Case report of olanzapine-associated elevation of serum creatine kinase in a 16-year-old boy with heat stroke.

Authors:  Mohammad Jafferany; Jennifer Lowry
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

4.  Acute rhabdomyolysis during treatment with amisulpride and metformin.

Authors:  Francesco Ursini; Elena Succurro; Alessandro Grembiale; Franco Arturi
Journal:  Eur J Clin Pharmacol       Date:  2009-12-18       Impact factor: 2.953

5.  Serum creatine kinase elevation associated with olanzapine treatment.

Authors:  Bhaskar Punukollu; Helen Rutherford
Journal:  BMJ Case Rep       Date:  2008-11-20

Review 6.  Antipsychotic-induced elevation of creatine kinase: a systematic review of the literature and recommendations for the clinical practice.

Authors:  Zacharias G Laoutidis; Kanellos T Kioulos
Journal:  Psychopharmacology (Berl)       Date:  2014-10-16       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.